Azzoli CG - Search Results

1

A phase I trial of intermittent high-dose gefitinib and fixed-dose docetaxel in patients with advanced solid tumors.

Fury MG, Solit DB, Su YB, Rosen N, Sirotnak FM, Smith RP, Azzoli CG, Gomez JE, Miller VA, Kris MG, Pizzo BA, Henry R, Pfister DG, Rizvi NA. Fury MG, et al. Among authors: azzoli cg. Cancer Chemother Pharmacol. 2007 Mar;59(4):467-75. doi: 10.1007/s00280-006-0286-6. Epub 2006 Aug 1. Cancer Chemother Pharmacol. 2007. PMID: 16896930 Clinical Trial.

2

Chemotherapy for early stage non-small cell lung cancer.

Kris MG, Azzoli CG. Kris MG, et al. Among authors: azzoli cg. Lung Cancer. 2001 Dec;34 Suppl 3:S49-52. doi: 10.1016/s0169-5002(01)00372-5. Lung Cancer. 2001. PMID: 11740994 Review.

3

Trastuzumab in the treatment of non-small cell lung cancer.

Azzoli CG, Krug LM, Miller VA, Kris MG, Mass R. Azzoli CG, et al. Semin Oncol. 2002 Feb;29(1 Suppl 4):59-65. doi: 10.1053/sonc.2002.31526. Semin Oncol. 2002. PMID: 11894015 Review.

4

Targeting lethal minimal residual disease in small cell lung cancer.

Patel JD, Krug LM, Azzoli CG, Gomez J, Kris MG, Miller VA. Patel JD, et al. Among authors: azzoli cg. Semin Oncol. 2003 Feb;30(1):79-85. doi: 10.1053/sonc.2003.50018. Semin Oncol. 2003. PMID: 12635092 Review.

5

A phase I trial of perillyl alcohol in patients with advanced solid tumors.

Azzoli CG, Miller VA, Ng KK, Krug LM, Spriggs DR, Tong WP, Riedel ER, Kris MG. Azzoli CG, et al. Cancer Chemother Pharmacol. 2003 Jun;51(6):493-8. doi: 10.1007/s00280-003-0599-7. Epub 2003 Apr 15. Cancer Chemother Pharmacol. 2003. PMID: 12695855 Clinical Trial.

6

10-propargyl-10-deazaaminopterin: an antifolate with activity in patients with previously treated non-small cell lung cancer.

Krug LM, Azzoli CG, Kris MG, Miller VA, Khokhar NZ, Tong W, Ginsberg MS, Venkatraman E, Tyson L, Pizzo B, Baez V, Ng KK, Sirotnak FM. Krug LM, et al. Among authors: azzoli cg. Clin Cancer Res. 2003 Jun;9(6):2072-8. Clin Cancer Res. 2003. PMID: 12796370 Clinical Trial.

7

Gemcitabine-induced peripheral edema: report on 15 cases and review of the literature.

Azzoli CG, Miller VA, Ng KK, Krug LM, Hensley ML, O'Reilly EM, Muller RJ, Kris MG. Azzoli CG, et al. Am J Clin Oncol. 2003 Jun;26(3):247-51. doi: 10.1097/01.COC.0000017782.24458.DD. Am J Clin Oncol. 2003. PMID: 12796593 Review.

8

American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003.

Pfister DG, Johnson DH, Azzoli CG, Sause W, Smith TJ, Baker S Jr, Olak J, Stover D, Strawn JR, Turrisi AT, Somerfield MR; American Society of Clinical Oncology. Pfister DG, et al. Among authors: azzoli cg. J Clin Oncol. 2004 Jan 15;22(2):330-53. doi: 10.1200/JCO.2004.09.053. Epub 2003 Dec 22. J Clin Oncol. 2004. PMID: 14691125 Review. No abstract available.

9

Bronchioloalveolar pathologic subtype and smoking history predict sensitivity to gefitinib in advanced non-small-cell lung cancer.

Miller VA, Kris MG, Shah N, Patel J, Azzoli C, Gomez J, Krug LM, Pao W, Rizvi N, Pizzo B, Tyson L, Venkatraman E, Ben-Porat L, Memoli N, Zakowski M, Rusch V, Heelan RT. Miller VA, et al. J Clin Oncol. 2004 Mar 15;22(6):1103-9. doi: 10.1200/JCO.2004.08.158. J Clin Oncol. 2004. PMID: 15020612

10

Imatinib mesylate lacks activity in small cell lung carcinoma expressing c-kit protein: a phase II clinical trial.

Krug LM, Crapanzano JP, Azzoli CG, Miller VA, Rizvi N, Gomez J, Kris MG, Pizzo B, Tyson L, Dunne M, Heelan RT. Krug LM, et al. Among authors: azzoli cg. Cancer. 2005 May 15;103(10):2128-31. doi: 10.1002/cncr.21000. Cancer. 2005. PMID: 15812822 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

111 results

Search Page

Filters